81 related articles for article (PubMed ID: 3366566)
1. Immunogenetic influence of Igh-1 phenotype on experimental herpes simplex virus type-1 corneal infection.
Opremcak EM; Wells PA; Thompson P; Daigle JA; Rice BA; Millin JA; Foster CS
Invest Ophthalmol Vis Sci; 1988 May; 29(5):749-54. PubMed ID: 3366566
[TBL] [Abstract][Full Text] [Related]
2. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice.
Opremcak EM; Rice BA; Wells PA; Foster CS
Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):305-12. PubMed ID: 2154415
[TBL] [Abstract][Full Text] [Related]
3. Chorioretinal disease patterns in congenic mice following intraocular inoculation with HSV-1.
Opremcak EM; Foster CS; Hemady R; Rice BA; Daigle JA; Raizman MB; Chung H; Zaltas M
Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1041-6. PubMed ID: 2543649
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice.
Hemady R; Opremcak EM; Zaltas M; Berger A; Foster CS
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1750-7. PubMed ID: 2547732
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
Tamesis RR; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
[TBL] [Abstract][Full Text] [Related]
7. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
[TBL] [Abstract][Full Text] [Related]
8. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
[TBL] [Abstract][Full Text] [Related]
9. Patterns of herpes simplex keratitis in inbred mice.
Stulting RD; Kindle JC; Nahmias AJ
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1360-7. PubMed ID: 4044164
[TBL] [Abstract][Full Text] [Related]
10. [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis].
Heiligenhaus A; Jayaraman S; Soukiasian S; Dorf M; Foster CS
Ophthalmologe; 1995 Aug; 92(4):484-91. PubMed ID: 7549333
[TBL] [Abstract][Full Text] [Related]
11. An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice.
Pepose JS; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1549-52. PubMed ID: 3040616
[TBL] [Abstract][Full Text] [Related]
12. Spread of HSV and establishment of latency after corneal infection in inbred mice.
Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975
[TBL] [Abstract][Full Text] [Related]
13. The role of cytokines in experimental herpes simplex keratitis.
Arrunategui-Correa V; Baltatzis S; Foster CS
Acta Virol; 1999 Oct; 43(5):325-9. PubMed ID: 10757234
[TBL] [Abstract][Full Text] [Related]
14. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
Thomas J; Rouse BT
J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
[TBL] [Abstract][Full Text] [Related]
15. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice.
Tamesis RR; Messmer EM; Rice BA; Dutt JE; Foster CS
Eye (Lond); 1994; 8 ( Pt 3)():298-306. PubMed ID: 7958034
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of murine latent HSV infection by epinephrine iontophoresis.
Willey DE; Trousdale MD; Nesburn AB
Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):945-50. PubMed ID: 6086546
[TBL] [Abstract][Full Text] [Related]
17. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
[TBL] [Abstract][Full Text] [Related]
18. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
[TBL] [Abstract][Full Text] [Related]
19. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
